阿兹夫定片
Search documents
医药产业高质量发展显成效 全省“两品一械”生产企业超2600家
He Nan Ri Bao· 2026-02-06 23:11
Group 1 - The core viewpoint of the article highlights the continuous improvement in drug safety and the high-quality development of the pharmaceutical industry in the province, with a significant increase in the number of production enterprises [1] - By the end of 2025, the province had a total of 2,618 "two products and one device" (drugs, cosmetics, and medical devices) production enterprises, representing a 53% increase compared to 2020 [1] - The drug safety inspection pass rate remains above 99%, with no major drug safety incidents reported [1] Group 2 - In 2025, the province approved 107 new drug approval numbers, with 60 new varieties passing the consistency evaluation for generic drugs [2] - The first class 1 innovative drug "Azvudine tablets" and the first antibody drug "Bevacizumab injection" were approved during the "14th Five-Year Plan" period [2] - The provincial drug regulatory authority aims to create a new ecosystem for pharmaceutical industry development through five major actions, focusing on political guidance, reform innovation, drug safety, industry ecology, and regulatory capacity enhancement [2]
新闻发布厅丨河南省高质量完成“十四五”规划系列主题新闻发布会之十五 统筹监管与服务 赋能高质量发展
He Nan Ri Bao· 2025-10-19 23:35
Core Viewpoint - The Henan provincial government is committed to high-quality development through effective market regulation, achieving significant growth in business entities and enhancing the overall market environment [1][2]. Group 1: Market Regulation Development - The market regulation system in Henan has added 3.675 million new business entities since the beginning of the 14th Five-Year Plan, representing a 47% increase compared to the end of the 13th Five-Year Plan [1]. - As of September 2023, the total number of business entities in Henan reached 11.487 million, ranking 4th nationwide [1]. - The provincial market regulation bureau has streamlined administrative processes, reducing the number of steps for business migration from 4 to 1 and cutting the processing time to 6 working days, which is 4 days faster than the national average [2]. Group 2: Quality Improvement Initiatives - The province has launched the "Quality Strong Province Construction Outline" and has awarded 128 enterprises the right to use the "Meiyu Brand" public brand [3]. - There has been a 64% increase in the issuance of valid certification certificates, totaling 125,400, and a 47% increase in certified organizations, reaching 36,400 [3]. - During the 14th Five-Year Plan, Henan added 52,855 valid invention patents and 1,103,900 registered trademarks, with 241 geographical indication protection products [3]. Group 3: Safety Measures - The market regulation system has adopted a "zero tolerance" approach to risk prevention and safety assurance, implementing various safety initiatives [4]. - Henan achieved an A-level rating in national food safety assessments for 2022 and 2023, with a consumer satisfaction score of 84.47 [4]. - The food safety inspection pass rate has consistently remained above 98% for several years [4]. Group 4: Innovation and Consumer Protection - The market regulation system supports innovation in pharmaceuticals and medical devices through tailored services and expedited processes [5]. - The province has cultivated 45,400 trusted consumption entities and has implemented a consumer rights protection system that has handled over 10.248 million consumer complaints, recovering 1.238 billion yuan in economic losses for consumers [5]. - The regulatory framework aims to enhance service quality and regulatory efficiency to contribute to the modernization of the region [5].